Literature DB >> 22459508

Feasibility and compliance with daily home electrocardiogram monitoring of the QT interval in heart transplant recipients.

Erik V Carter1, Kathleen T Hickey, David M Pickham, Lynn V Doering, Belinda Chen, Patricia R E Harris, Barbara J Drew.   

Abstract

BACKGROUND: Recent evidence suggests that acute allograft rejection after heart transplantation causes an increased QT interval on electrocardiogram (ECG). The aims of this pilot study were to (1) determine whether heart transplant recipients could achieve compliance in transmitting a 30-second ECG every day for 1 month using a simple ECG device and their home telephone, (2) evaluate the ease of device use and acceptability by transplant recipients, and (3) evaluate the quality of transmitted ECG tracings for QT-interval measurement.
METHODS: A convenience sample of adult heart transplant recipients were recruited and trained to use the device (HeartOne, Aerotel Medical Systems, Holon, Israel). Lead II was used with electrodes that were easy to slip on and off (expandable metal wrist watch-type electrode for right wrist and C-shaped band electrode for left ankle). Patients used a toll-free number with automated voice prompts to guide their ECG transmission to the core laboratory for analysis.
RESULTS: Thirty-one subjects (72% were male; mean age of 52 ± 17 years; 37% were nonwhite) achieved an ECG transmission compliance of 73.4% (daily) and 100% (weekly). When asked, how difficult do you think it was to record and transmit your ECG by phone, 90% of subjects replied "somewhat easy" or "extremely easy." Of the total 644 ECGs that were transmitted by subjects, 569 (89%) were acceptable quality for QT-interval measurement. The mean QTc was 448 ± 44 ms (440 ± 41 ms for male subjects and 471 ± 45 ms for female subjects). Eleven subjects (35%) had an extremity tremor, and 19 subjects (55%) had ≥ 1+ left leg edema. Neither of these conditions interfered with ECG measurements.
CONCLUSION: Transplant recipients are compliant with recording and transmitting daily and weekly ECGs.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22459508      PMCID: PMC3387335          DOI: 10.1016/j.hrtlng.2012.02.012

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  8 in total

1.  Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis.

Authors:  J Stehlik; R C Starling; M A Movsesian; J C Fang; R N Brown; M L Hess; N P Lewis; J K Kirklin
Journal:  J Heart Lung Transplant       Date:  2006-12       Impact factor: 10.247

2.  Accurate electrocardiographic assessment of the QT interval: teach the tangent.

Authors:  Pieter G Postema; Jonas S S G De Jong; Ivo A C Van der Bilt; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2008-04-01       Impact factor: 6.343

3.  Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009.

Authors:  David O Taylor; Josef Stehlik; Leah B Edwards; Paul Aurora; Jason D Christie; Fabienne Dobbels; Richard Kirk; Anna Y Kucheryavaya; Axel O Rahmel; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2009-10       Impact factor: 10.247

4.  Diurnal variations of QT interval after cardiac transplantation.

Authors:  D Alexopoulos; A Rynkiewicz; S Yusuf; J A Johnston; P Sleight; M H Yacoub
Journal:  Am J Cardiol       Date:  1988-02-15       Impact factor: 2.778

5.  [Predictive value of ECG changes for acute cardiac rejections in heart transplant recipients].

Authors:  Gero Tenderich; Jama Jahanyar; Armin Zittermann; Stefanie S Schleithoff; Stefan Wlost; Reiner Körfer
Journal:  Med Klin (Munich)       Date:  2006-02-15

6.  Daclizumab to prevent rejection after cardiac transplantation.

Authors:  Ray E Hershberger; Randall C Starling; Howard J Eisen; Claes-Håkan Bergh; Robert L Kormos; Robert B Love; Adrian Van Bakel; Robert D Gordon; Rina Popat; Louise Cockey; Richard D Mamelok
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

7.  Endomyocardial biopsy as risk factor in the development of tricuspid insufficiency after heart transplantation.

Authors:  A I Fiorelli; G H B Coelho; J L Oliveira; V D Aiello; L A Benvenuti; A Santos; A Chi; A Tallans; M L Igushi; F Bacal; E A Bocchi; N A G Stolf
Journal:  Transplant Proc       Date:  2009-04       Impact factor: 1.066

8.  Limited utility of endomyocardial biopsy in the first year after heart transplantation.

Authors:  Iman M Hamour; Margaret M Burke; Alex D Bell; Mathen G Panicker; Rajasi Banerjee; Nicholas R Banner
Journal:  Transplantation       Date:  2008-04-15       Impact factor: 4.939

  8 in total
  2 in total

1.  Measurement of the QT interval using the Apple Watch.

Authors:  Carmen Anna Maria Spaccarotella; Serena Migliarino; Annalisa Mongiardo; Jolanda Sabatino; Giuseppe Santarpia; Salvatore De Rosa; Antonio Curcio; Ciro Indolfi
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

2.  Towards remote monitoring in pediatric care and clinical trials-Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity, heart rate and sleep in healthy children.

Authors:  M D Kruizinga; N van der Heide; A Moll; A Zhuparris; Y Yavuz; M L de Kam; F E Stuurman; A F Cohen; G J A Driessen
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.